Pfizer to supply UNICEF up to 4M COVID-19 oral treatment for low- and middle-income countries

This includes all low- and lower-middle-income countries and some upper-middle-income countries in Sub-Saharan Africa as well as countries that have transitioned from lower-middle to upper-middle-income status in the last five years, accounting for approximately 53 percent of the world’s population.

Pfizer expects supply to be available to support orders this month, and will continue throughout 2022, pending regulatory authorization or approval and according to country needs.All low- and lower-middle-income countries will be offered the treatment courses at the not-for-profit price while upper-middle-income countries will pay the price defined in Pfizer’s tiered pricing approach.

“We have seen the negative impacts of COVID-19 in every part of the world and know that we must work towards access for all people regardless of where they live or their circumstances,” said Albert Bourla, Pfizer Chairman and Chief Executive Officer. “Supplying to UNICEF is an important part of our comprehensive strategy to accelerate access to Paxlovid to treat COVID-19 infection as quickly as possible and at an affordable price in order to decrease the strain on healthcare systems and help save lives in low- and middle-income countries,” Bourla added.Pfizer has raised its production projections for Paxlovid, with the ability to produce up to 120 million courses of treatment by the end of 2022, pending global demand.

The company has initiated bilateral outreach to more than 100 countries around the world and has entered into agreements with multiple countries.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Over 17,000 schools nominated to join in-person classes ‘progressive expansion’NEARLY 17,500 public and private schools in the country are nominated to join the “progressive expansion” of in-person classes amid the coronavirus disease (Covid-19) pandemic,...
Source: sunstaronline - 🏆 18. / 59 Read more »

Current vaccines still effective vs. 'Omicron XE' –expertThe COVID-19 vaccines currently administered in the country still remain effective against the possible new coronavirus variant linked to the more transmissible Omicron, infectious disease expert Dr. Rontgene Solante said Tuesday. Hindi yan effective against the virus eversince, dahil hindi naman virus ang pinatay nyan kundi pinapraktice lang ang katawan ng tao mag response kung may totoong virus na pumapasok sa katawan. It's gene theraphy, not a true vaccine.
Source: gmanews - 🏆 11. / 68 Read more »

DoH eyes annual Covid-19 shotsTHE Department of Health (DoH) is studying the possibility of giving free anti-Covid-19 shots once a year.In a radio interview on Monday, Health Undersecretary and National... no, thank u
Source: TheManilaTimes - 🏆 2. / 92 Read more »